New Diabetes Diagnosis Associated With Pancreatic Cancer

Share this content:
New Diabetes Diagnosis Associated With Pancreatic Cancer
New Diabetes Diagnosis Associated With Pancreatic Cancer

(HealthDay News) — There is a strong association between pancreatic ductal adenocarcinoma (PDAC) and recently diagnosed diabetes mellitus (DM), according to a systematic review and meta-analysis published in the March issue of the Annals of Surgical Oncology.

Pikli Batabyal, MBBS, from the University of Melbourne in Australia, and colleagues conducted a systematic review and identified 88 independent studies (50 cohort and 39 case-control) examining the association between DM and PDAC. A "random effects" approach was used to calculate summary estimates for case-control and cohort studies.

RELATED: Pancreatic Cancer Resource Center

The researchers found that the overall summary-combined relative risk was 1.97, with considerable heterogeneity observed that could not be attributed to analyses of any subgroup. The greatest risk of PDAC was seen early after DM diagnosis, but risk remained elevated for a prolonged period. There was variation in the individual-level relative risk from 6.69 at less than one year to 1.36 at 10 years.

"The results demonstrate a strong association between PDAC and recently diagnosed DM, which may be attributed to a paraneoplastic effect," the researchers wrote. "Selective screening of patients with new-onset DM for PDAC needs to be considered."


  1. Batabayal P, Vander Hoorn S, Christophi C, et al. Association of Diabetes Mellitus and Pancreatic Adenocarcinoma: A Meta-Analysis of 88 Studies. Ann Surg Oncol. 2014; doi:10.1245/s10434-014-3625-6.

Related Resources

Related Slideshows

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs